NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
25/07/2026
Voltar para busca
Dado oficial do USPTO
IMMUNORAD
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
IMMUNORAD
ST13
US500000079253804Classe
16, 36, 41, 42, 44
Pedido
79253804
Registro
5917326
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
25/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
16, 36, 41, 42, 44
Data de depósito
19/12/2018
Data de registro
26/11/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/07/2026
Última transação
25/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
VILLEJUIF CEDEX, FR
Examinador
COWARD, JEFFERY
Localização atual
Historical data usage
Titulares e representantes
Titulares
INSTITUT GUSTAVE-ROUSSY
Representantes
Jennifer C. Debrow Taft Stettinius & Hollister LLP
Classificação técnica
Classes Nice
Classe 16Classe 36Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 16
magazinesnewspapersperiodicalsbrochuresleafletsbooks all in the fields of medicinesurgerycancer treatmentmedical and scientific research
Classe 36
Charitable fund-raisingCharitable raising of funds and financial sponsorshipin particular for business partnersof the research for cancer preventioncancer prevention programs and medical equipment and scientific research programs aimed at fighting cancer
Classe 41
Education servicesorganizing and conducting of colloquiumsconferencescongressessymposiumsseminars in the fields of medicinesurgerycancer treatmentmedical and scientific research; Training services in the fields of medicinesurgerycancer treatmentmedical and scientific research; organization of competitionsevents and exhibitionsfor cultural or educational purposes; Organizing of cultural shows; Entertainment servicescontinuing radio and television shows in the fields of medicinesurgerycancer treatment and preventionmedical and scientific research; organization of shows for cultural purposes; health club servicesproviding instruction and equipment in the field of physical exercise; Teaching in the fields of medicalsurgical and scientific research; Entertainment servicesorganization of events for cultural or entertainment purposes in the nature of gala parties featuring live showsmusic and food and drinks
Classe 42
Scientific and medical research; product research and development of new medical products; Research in bacteriologybiologychemistry; Providing scientific information in the field of cancer control ; clinical research in the field of cancer prevention and treatment; biological research; and laboratory research in the field of bacteriologybiologychemistry related to cancer prevention
Classe 44
Hospital services; Medical analysis services for the diagnosis and treatment of cancer; Expert medical advisory services; medical and health care services; medical services in the field of surgery; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical imaging services; radiotherapy services; brachytherapy services; Medical dosimetry services for treating cancer; providing information in the field of cancer treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
25/07/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
22/07/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
01/04/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/11/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
27/10/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/01/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/12/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/04/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
17/03/2020
FIMP
FINAL DISPOSITION PROCESSED
17/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/02/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/02/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/01/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
26/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/09/2019
PUBO
PUBLISHED FOR OPPOSITION
10/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2019
ALIE
ASSIGNED TO LIE
07/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/07/2019
RFNT
REFUSAL PROCESSED BY IB
12/04/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
23/03/2019
RFRR
REFUSAL PROCESSED BY MPU
23/03/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16/03/2019
MAFR
APPLICATION FILING RECEIPT MAILED
16/03/2019
CNRT
NON-FINAL ACTION WRITTEN
15/03/2019
DOCK
ASSIGNED TO EXAMINER
14/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/03/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IMMUNORAD ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.